Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
102K
-
Shares change
-
+7.73K
-
Total reported value, excl. options
-
$1.5M
-
Value change
-
+$113K
-
Number of buys
-
2
-
Price
-
$14.60
Significant Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q4 2023
3 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102K shares
of 101M outstanding shares and own 0.1% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.81M shares), Atlas Venture Life Science Advisors, LLC (7.61M shares), BlackRock Inc. (5.13M shares), VANGUARD GROUP INC (4.77M shares), FRANKLIN RESOURCES INC (4.24M shares), BRAIDWELL LP (4.22M shares), FMR LLC (3.97M shares), STATE STREET CORP (3.38M shares), Pictet Asset Management Holding SA (2.57M shares), and VIKING GLOBAL INVESTORS LP (2.56M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.